Prognosis

Pfizer to Deliver U.S. Vaccine Doses Faster Than Expected

Labeling change means 200 million doses on hand by May’s end
Drugmaker working on booster shot to shield against variants

Error:

Could not download required scripts. Please update your browser or turn off ad blocker to continue to watch.

Pfizer to Deliver U.S. Vaccine Doses Two Months Early, CEO Says

How easy or hard was it to use Bloomberg.com today?

Share feedback

Have a confidential tip for our reporters? Get in Touch

Before it’s here, it’s on the Bloomberg Terminal

LEARN MORE

By Riley Griffin

January 26, 2021 at 1:51 PM UTC

Updated on

January 26, 2021 at 3:29 PM UTC

This article is for subscribers only.

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

Pfizer Inc. will be able to supply the U.S. with 200 million Covid-19 vaccine doses by the end of May, two months sooner than previously expected, according to its top executive.

Have a confidential tip for our reporters? Get in Touch

Before it’s here, it’s on the Bloomberg Terminal

LEARN MORE